We did not detect an association between IL-6 concentrations and patients with established CV disease in our NAFLD population, however this was because only 9.5% (Table 1) of our patient group had established CV disease. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.